Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Conference News PCR London Valves 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Conference News PCR London Valves 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

TCT 389: First Report of Percutaneous Left Atrial Appendage Occlusion with Watchman FLX with TEE Guidance and Zero-contrast

Presenter: Tarun Chakravarty

September 19, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

News Daily News

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

Todd Neale

August 17, 2022

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

Shelley Wood

August 15, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

Intracardiac echocardiography guided antegrade transseptal valve-in-valve TAVR under conscious sedation with zero contrast

Presenter: Alok Sharma

June 08, 2022

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

Advertisement

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

TCT 389: First Report of Percutaneous Left Atrial Appendage Occlusion with Watchman FLX with TEE Guidance and Zero-contrast

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Intracardiac echocardiography guided antegrade transseptal valve-in-valve TAVR under conscious sedation with zero contrast

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

April 2022 News Roundup

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

March 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content